Daniel M. Halperin, MD

Daniel M. Halperin, MD, is an associate professor in the Division of Cancer Medicine, Department of Gastrointestinal Medical Oncology, at The University of Texas MD Anderson Cancer Center in Houston. He also serves as chair of the Neuroendocrine Tumor Multidisciplinary Conference (Tumor Board) and as clinical medical director of the Gastrointestinal Cancer Center at MD Anderson Cancer Center. Dr Halperin earned his medical degree from Weill Cornell Medical College. He completed his fellowship training in medical oncology at MD Anderson Cancer Center and his residency in internal medicine at Brigham and Women's Hospital.

Dr Halperin, who is board certified in medical oncology and internal medicine, is a clinical investigator primarily focused on the development of novel treatments for patients with neuroendocrine tumors (NETs). As a clinical investigator, he leads clinical trials of new drugs for patients with NETs at MD Anderson Cancer Center, and he works with a team of laboratory and population scientists to understand more fully the molecular underpinnings and clinical manifestations of NETs.

He serves on the National Comprehensive Cancer Network (NCCN) Neuroendocrine and Adrenal Tumors Guideline Committee, the NCCN Neuroendocrine Tumors Panel, the Neuroendocrine Tumor Research Foundation Board of Scientific Advisors, the Healing NET Foundation Scientific Advisory Committee, and the North American Neuroendocrine Tumor Society (NANETS) Board of Directors. He is also past chair of the NANETS Scientific Review & Research Committee.